Moxetumomab Pasudotox-Tdfk: Uses, Dosage, Precautions, Side Effects, and Pharmacological Aspects
Moxetumomab pasudotox-tdfk treats relapsed or refractory hairy cell leukemia by targeting CD22 on B-cells and delivering a cytotoxin to kill cancer cells.
